Phagocytosis‐Activating Nanocomplex Orchestrates Macrophage‐Mediated Cancer Immunotherapy
Advanced Materials · 2025
DOI: 10.1002/adma.202500982 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2025. Verfasst von Hua Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College & Hospital of Stomatology, Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province, Hefei, 230032, China. Hauptthemen laut MEDLINE: Phagocytosis, Immunotherapy, Macrophages, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
The phagocytosis of macrophages to tumor cells represents an alluring strategy for cancer immunotherapy; however, its effectiveness is largely hindered by the detrimental upregulation of anti‐phagocytic signals and insufficient expression of pro‐phagocytic signals of tumor cells. Here, a pro‐phagocytic polymer‐based nanocomplex is designed to promote the macrophage engulfment of tumor cells through concurrent modulation of both the “eat me” and “don't eat me” signals. The nanocomplex MNC CD47i‐CALRt is formed by complexing a synthetic PAMAM derivative (G4P–C7A) that is capable of intrinsically inducing the exposure of calreticulin (CALR, a crucial pro‐phagocytic protein) and a small inference RNA that can inhibit the expression of CD47 (a primary anti‐phagocytic protein). MNC CD47i‐CALRt can significantly delay tumor growth and prolong the survival of tumor‐bearing mice with negligible hematopoietic toxicity in multiple murine colorectal cancer models. Furthermore, the pro‐phagocytic capacity of MNC CD47i‐CALRt is validated in the patient‐derived tumor organoid model. Collectively, the phagocytosis‐promoting nanocomplex provides a simple and potent strategy for boosting macrophage‐mediated cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College & Hospital of Stomatology, Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province, Hefei, 230032, China.
- School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou, 511442, China.
- School of Medicine, South China University of Technology, Guangzhou, 510006, China.
- National Engineering Research Center for Tissue Restoration and Reconstruction, and Guangdong Provincial Key Laboratory of Biomedical Engineering, South China University of Technology, Guangzhou, 510006, China.
- Innovation Centre of Ministry of Education for Development and Diseases, School of Medicine, South China University of Technology, Guangzhou, 510006, China.
ORCID-Profile: Jin-Zhi Du
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Guangzhou Science and Technology Planning Project
- National Key Research and Development Program of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Huang, H., Tong, Q. S., Zhang, J. Y., Miao, W. M., Yu, H. H., Wang, J., Shen, S., & Du, J. Z. (2025). Phagocytosis‐Activating Nanocomplex Orchestrates Macrophage‐Mediated Cancer Immunotherapy. Advanced Materials. https://doi.org/10.1002/adma.202500982
Vancouver
Huang H, Tong QS, Zhang JY, Miao WM, Yu HH, Wang J, et al. Phagocytosis‐Activating Nanocomplex Orchestrates Macrophage‐Mediated Cancer Immunotherapy. Advanced Materials. 2025. doi:10.1002/adma.202500982
BibTeX
@article{Huang2025,
author = {Huang, Hua and Tong, Qi-Song and Zhang, Jing-Yang and Miao, Wei-Min and Yu, Hui-Han and Wang, Jun and Shen, Song and Du, Jin-Zhi},
title = {Phagocytosis‐Activating Nanocomplex Orchestrates Macrophage‐Mediated Cancer Immunotherapy},
journal = {Advanced Materials},
year = {2025},
doi = {10.1002/adma.202500982}
}
EUVIMED